Advertisement

Oncological Emergencies

  • Sameer Rathi
Chapter

Abstract

  • Oncotherapy patients who present to the emergency department are experiencing significant disease conditions; however, frivolous they may appear to be, unless proven otherwise.

  • Early fluid resuscitation, rapid empirical diagnosis, blood and urine cultures and early commencement of broad-spectrum antibiotics are primary interventions required in the emergency department.

  • Spinal cord compression should be ruled out in chemotherapy patients with back pain.

  • Superior vena cava syndrome is rarely life threatening and requires tissue diagnosis of malignancy, prior to treatment initiation.

  • Neoplastic pericardial effusion can arise insidiously, and bedside echocardiography is the modality of choice for establishing the diagnosis.

  • Hypercalcaemia due to malignancy is associated with a poor prognosis.

Keywords

Zoledronic Acid Pericardial Effusion Tumour Lysis Syndrome Pericardial Tamponade Gallium Nitrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Krimsky WS, Behrens RJ, Kerkvliet GJ. Oncologic emergencies for the internist. Cleve Clin J Med. 2002;69:209.CrossRefPubMedGoogle Scholar
  2. 2.
    Higdon ML, Higdon JA. Treatment of oncologic emergencies. Am Fam Physician. 2006;74:1873.PubMedGoogle Scholar
  3. 3.
    Halfdanarson TR, Hogan WJ, Moynihan TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc. 2006;81:835. Erratum in: Mayo Clin Proc 81: 1509, 2006.CrossRefPubMedGoogle Scholar
  4. 4.
    Cohen LF, Balow JE, Magrath IT, et al. Acute tumour lysis syndrome: a review of 37 patients with Burkitt’s lymphoma. Am J Med. 1980;68(4):486–91.Google Scholar
  5. 5.
    Fojo AT. Tumour lysis syndrome. In: DeVita VT et al., editors. Cancer: principles and practice of oncology. 7th ed. Philadelphia: Lippincott-Raven; 2005.Google Scholar
  6. 6.
    Holdsworth M, Nguyen P. Role of i.v. allopurinol and rasburicase in tumour lysis syndrome. Am J Health Syst Pharm. 2003;60(21):2213–222.Google Scholar
  7. 7.
    Koyamangalath K. Tumour lysis syndrome. Emedicine. 2006. Available at http://emedicine.medscape.com/article/282171.
  8. 8.
    London Cancer Alliance(LCA) Acute clinical guidelines. 2013.Pg. 23–25, 35.Google Scholar
  9. 9.
    Grill V, Martin TJ. Hypercalcemia of malignancy. Rev Endocr Metab Disord. 2000;1:253.CrossRefPubMedGoogle Scholar
  10. 10.
    Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol. 2000;27(3):322–34.PubMedGoogle Scholar
  11. 11.
    Wudel LJ, Nesbitt JC. Superior vena cava syndrome. Curr Treat Options Oncol. 2001;2:77.CrossRefPubMedGoogle Scholar
  12. 12.
    Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007;356:1862. Erratum in: N Engl J Med 358: 1083, 2008.CrossRefPubMedGoogle Scholar
  13. 13.
    Yarlagadda C: Cardiac Tamponade, Emedicine 2006. Available at http://emedicine.medscape.com/article/152083.
  14. 14.
    Pass HI. Malignant pleural and pericardial effusions. In: DeVita VT et al., editors. Cancer: principles and practice of oncology. 5th ed. Philadelphia: JB Lippincott; 1997.Google Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Accident and Emergency DepartmentKokilaben Dhirubhai Ambani Hospital and Medical Research CenterMumbaiIndia

Personalised recommendations